News

Search Articles

76 - 81 of 81 Results Clear All

September 10, 2012

Gladstone Scientists Develop Innovative Technique to Monitor and Decipher the Dormant AIDS Virus Concealed in Cells

SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection—by devising a method to precisely track the life cycle of individual cells infected with HIV, the virus that causes AIDS.

HIV/AIDS Weinberger Lab

December 20, 2011

Gladstone and UCSF Scientists Provide a Global View of How HIV/AIDS Hijacks Cells During Infection

SAN FRANCISCO, CA—Gladstone Institutes scientist Nevan Krogan, PhD, today is announcing research that identifies how HIV—the virus that causes AIDS—hijacks the body's own defenses to promote infection. This discovery could one day help curb the spread of the HIV/AIDS pandemic.

HIV/AIDS Krogan Lab

Gladstone in the News December 16, 2010

Gladstone-Led HIV Study Tops Time List

San Francisco Business Times—Ten years ago, an international HIV study led by then Gladstone Investigator Robert Grant, MD, MPH, showed that the antiretroviral drug Truvada taken as a prophylactic could reduce the risk of infection by HIV, a study that was declared medical breakthrough of the year by Time magazine.

Gladstone Experts HIV/AIDS

November 23, 2010

Deciphering How CD4 T Cells Die During HIV Infection

SAN FRANCISCO, CA—Scientists at Gladstone Institute of Virology and Immunology have solved a long-standing mystery about HIV infection—namely how HIV promotes the death of CD4 T cells. It is the loss of this critical subset of immune cells that leads to the development of AIDS.

Greene Lab HIV/AIDS

November 22, 2010

Use of HIV Medications Reduces Risk of HIV Infection in Uninfected People

San Francisco, CA—In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofov

Grant Lab HIV/AIDS

January 3, 2010

Gladstone Scientists Identify Agent That May Inhibit HIV Infectivity

SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have discovered a new agent that might inhibit the infectivity of HIV. The agent, surfen, impairs the action of a factor in semen that greatly enhances the viral infection.

Greene Lab HIV/AIDS

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media

Are You a Journalist Looking to Write about Gladstone?

Sign Up for Our Newsletter

Congrats to Jennifer Doudna, winner of the 2020 Nobel Prize in Chemistry!